PeptideDB

Pomolic acid 13849-91-7

Pomolic acid 13849-91-7

CAS No.: 13849-91-7

Randialic acid A (Pomolic acid) is a pentacyclic triterpene extracted from Euscaphis japonica. Randialic acid A (Pomolic
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Randialic acid A (Pomolic acid) is a pentacyclic triterpene extracted from Euscaphis japonica. Randialic acid A (Pomolic acid) inhibits tumor cell growth and causes apoptosis. Randialic acid A (Pomolic acid) has potential in prostate cancer.

Physicochemical Properties


Molecular Formula C30H48O4
Molecular Weight 472.69972
Exact Mass 472.355
CAS # 13849-91-7
PubChem CID 382831
Appearance White to off-white solid powder
Density 1.1±0.1 g/cm3
Boiling Point 586.2±50.0 °C at 760 mmHg
Flash Point 322.4±26.6 °C
Vapour Pressure 0.0±3.7 mmHg at 25°C
Index of Refraction 1.568
LogP 7.4
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 1
Heavy Atom Count 34
Complexity 923
Defined Atom Stereocenter Count 10
SMILES

C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@]1(C)O)C)C(=O)O

InChi Key ZZTYPLSBNNGEIS-OPAXANQDSA-N
InChi Code

InChI=1S/C30H48O4/c1-18-10-15-30(24(32)33)17-16-27(5)19(23(30)29(18,7)34)8-9-21-26(4)13-12-22(31)25(2,3)20(26)11-14-28(21,27)6/h8,18,20-23,31,34H,9-17H2,1-7H3,(H,32,33)/t18-,20+,21-,22+,23-,26+,27-,28-,29-,30+/m1/s1
Chemical Name

(1R,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro DNA fragmentation demonstrated the ability of pomolic acid, or randialic acid A, to cause apoptosis in GBM cells. Reactive oxygen species (ROS) generation is necessary for pomanoate-induced apoptosis. Moreover, it causes the uncoupling of the mitochondrial membrane potential and the activation of caspase-3 and -9 [2].
References

[1]. Pomolic acid induces apoptosis and inhibits multidrug resistance protein MRP1 and migration in glioblastoma cells.Oncol Rep. 2017 Oct;38(4):2525-2534.

[2]. Pomolic Acid Ameliorates Fibroblast Activation and Renal Interstitial Fibrosis through Inhibition of SMAD-STAT Signaling Pathways.Molecules. 2018 Sep 3;23(9). pii: E2236.

Additional Infomation Pomolic acid is a triterpenoid. It has a role as a metabolite.
Pomolic acid has been reported in Rosa woodsii, Perilla frutescens, and other organisms with data available.
See also: Sanguisorba officinalis whole (part of).

Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~211.55 mM)
Solubility (In Vivo) Solubility in Formulation 1: 2.5 mg/mL (5.29 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: 2.5 mg/mL (5.29 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (5.29 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1155 mL 10.5775 mL 21.1551 mL
5 mM 0.4231 mL 2.1155 mL 4.2310 mL
10 mM 0.2116 mL 1.0578 mL 2.1155 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.